PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab-Reference-Cited by-同舟云学术

PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab

Published:2018-06 Issue: Volume:120 Page:108-112
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Guibert Nicolas,Delaunay Myriam,Lusque Amélie,Boubekeur Nadia,Rouquette Isabelle,Clermont Estelle,Mourlanette Jean,Gouin Sandrine,Dormoy Inge,Favre Gilles,Mazieres Julien,Pradines Anne

Funder

La Ligue contre le Cancer

Toulouse University Hospital (DRCI: Direction de la Recherche Clinique et de l’Innovation)

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference14 articles.

1. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N. Engl. J. Med.,2016

2. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer;Rizvi;Science,2015

3. Programmed cell death 1 (PD-1) ligand (PD-L1) expression in solid tumors as a predictive biomarker of benefit from PD-1/PD-L1 axis inhibitors: a systematic review and meta-analysis;Khunger;JCO Precis. Oncol.,2017

4. Change in PD-L1 expression after acquiring resistance to gefitinib in EGFR-mutant non-small-cell lung cancer;Han;Clin. Lung Cancer,2016

5. 81P Radiation resistance induced immunity evasion by evoking PD-L1 expression;Gong;J. Thorac. Oncol.,2016

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma cell-free RNA PD-L1 or tissue PD-L1 protein expression and outcomes with first-line immunotherapy in metastatic non-small cell lung cancer;The Journal of Liquid Biopsy;2024-03

2. Prognostic value of circulating tumor cells combined with neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma;World Journal of Gastrointestinal Oncology;2024-02-15

3. Liquid biopsy in lung cancer;Clinica Chimica Acta;2024-02

4. Circulating tumor cells reveal early predictors of disease progression in patients with stage III NSCLC undergoing chemoradiation and immunotherapy;Cell Reports;2024-02

5. Meta-Analysis of Circulating Tumor Cell PD-L1 Expression and the Association with Clinical Outcomes in Non-Small Cell Lung Cancer;Clinical Chemistry;2024-01